Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Research Support, Non-U.S. Gov't"
topic_facet:"Antibodies, Monoclonal"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
PubPharm (362)
1
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis : 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Ritchlin, C.
|
Coates, L.
|
McInnes, I.
| +12
Wird geladen...
2
Efficacy and safety of emapalumab in macrophage activation syndrome
enthalten in:
Annals of the rheumatic diseases
| 2023
von
De Benedetti, F.
|
Grom, A.
|
Brogan, P.
| +14
CommentIn: Nat Rev Rheumatol. 2023 Jun;19(6):326. - PMID 37147459
Wird geladen...
3
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy : efficacy and safety results of a randomised controlled phase III study
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Feist, E.
|
Fatenejad, S.
|
Grishin, S.
| +6
Wird geladen...
4
Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate : efficacy and safety results of a randomised controlled phase III study
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Nasonov, E.
|
Fatenejad, S.
|
Feist, E.
| +8
Wird geladen...
5
Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis : 16-week results from a randomised, placebo-controlled, phase 3 trial
enthalten in:
Annals of the rheumatic diseases
| 2021
von
Wei, J.
|
Kim, T.
|
Kishimoto, M.
| +54
CommentIn: Ann Rheum Dis. 2023 Jul;82(7):e168. - PMID 34172501
Wird geladen...
6
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis : results from a large US registry study
enthalten in:
Annals of the rheumatic diseases
| 2021
von
Pappas, D.
|
St John, G.
|
Etzel, C.
| +8
CommentIn: Ann Rheum Dis. 2022 Nov;81(11):e224. - PMID 33177099
Wird geladen...
7
Axial involvement in patients with early peripheral spondyloarthritis : a prospective MRI study of sacroiliac joints and spine
enthalten in:
Annals of the rheumatic diseases
| 2021
von
Renson, T.
|
Carron, P.
|
De Craemer, A.
| +8
Wird geladen...
8
GO-DACT : a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
enthalten in:
Annals of the rheumatic diseases
| 2020
von
Vieira-Sousa, E.
|
Alves, P.
|
Rodrigues, A.
| +21
Wird geladen...
9
Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13 : the weight of nocebo effect
enthalten in:
Annals of the rheumatic diseases
| 2020
von
Germain, V.
|
Scherlinger, M.
|
Barnetche, T.
| +2
Wird geladen...
10
Achieving remission in psoriatic arthritis by early initiation of TNF inhibition : a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate
enthalten in:
Annals of the rheumatic diseases
| 2019
von
van Mens, L.
|
de Jong, H.
|
Fluri, I.
| +5
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Filter aufheben
Thema: Antibodies, Monoclonal
Medienart
362
Aufsätze
245
E-Artikel
245
E-Ressourcen
117
Gedruckte Aufsätze
Zeitschriftentitel
362
Annals of the rheumatic diseases
Thema
Antibodies, Monoclonal
Research Support, Non-U.S. Gov't
334
Journal Article
255
Antirheumatic Agents
168
B72HH48FLU
168
Infliximab
163
Tumor Necrosis Factor-alpha
132
Antibodies, Monoclonal, Humanized
118
Randomized Controlled Trial
108
Multicenter Study
91
Adalimumab
91
FYS6T7F842
85
Methotrexate
84
YL5FZ2Y5U1
72
Immunoglobulin G
67
Etanercept
67
OP401G7OJC
65
Receptors, Tumor Necrosis Factor
47
Klinische Studie
44
Comparative Study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
319
2000-
10
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Sprache
362
Englisch
Haven't found what you're looking for?
Wird geladen...